TrialBMC cancer2017

Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) - a study protocol.

Dennis Schrijnders et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.